de

Greiner Bio-One supports leukaemia aid with typing campaign in Kremsmünster

Greiner Bio-One
13. February 2025

On 12 February, Greiner Bio-One organised a typing campaign for its employees together with the association 'Giving for Life - Leukaemia Aid Austria'.

Mitarbeitende von Greiner Bio-One bei der Typisierung

Kremsmünster, February 2025 - On 12 February, Greiner Bio-One and the association 'Geben für Leben - Leukämiehilfe Österreich' invited all employees at the Kremsmünster site to a typing campaign.

“I am very pleased that we are making a valuable contribution to people's health, not only through our high-quality product solutions, which are also used in cancer research, but also through our long-standing cooperation with Geben für Leben. Each of us can help - and I am proud that once again many colleagues have taken advantage of this opportunity.”

Ilke Panzer, CEO of Greiner Bio-One International GmbH

Typing with a cheek swab

Typing is done with a cheek swab and takes only a few minutes. If the HLA values (parts of the DNA) of the patient and the typed person match, the latter's stem cell donation could potentially save the patient's life.

Sharing the responsibility

When chemotherapy or drug treatment is ineffective, stem cell donation is the last resort in the fight against leukaemia, rare blood diseases and genetic defects. This is exactly where the association 'Geben für Leben - Leukämiehilfe Österreich' comes in: to find life-saving stem cell donors for these patients. Greiner Bio-One has been supporting the association since 2021. 

Downloads

About Bio-One International GmbH

Greiner Bio-One specializes in the development, production and distribution of high-quality plastic laboratory products. The company is a technology partner for hospitals, laboratories, universities, research institutes, and the diagnostic, pharmaceutical and biotechnology industries. Greiner Bio-One is split into three divisions – Preanalytics, BioScience and Sterilization. As an Original Equipment Manufacturer (OEM), Greiner Bio-One provides individual solutions in the area of custom-made design developments and production processes for the life sciences and medical sectors.  In 2023, Greiner Bio-One International GmbH generated a turnover of 637 million euros and had 2,659 employees, 29 subsidiaries and numerous distribution partners in over 100 countries. Greiner Bio-One is part of Greiner AG, which is based in Kremsmünster (Austria).

Website of Greiner Bio-One
Media Contact
Julia Franke, Expert Global Communication, Greiner Bio-One
Julia Franke, Expert Global Communication at Greiner Bio-One
+4366488920515
julia.franke(at)gbo.com
 
Stay up to date with the press mailing list
Add to press mailing list